Streamlining Clinical Development

  • How RWE can help Biotechs optimize the value of their asset

    How RWE can help Biotechs optimize the value of their asset

    Read More
  • Navigating Covid-19 to Support Next-Gen Patient Focused Treatments

    Navigating Covid-19 to Support Next-Gen Patient Focused Treatments

    Read More
  • ×

    Let's start a conversation...

    First Name
    Last Name
    Job Title
    Company Name
    Country
    Therapeutic Area Interest - optional
    Tell us how we can help
    Thank you! We'll be in touch soon.
    Error - something went wrong!
  • Parexel Biotech Brochure

    Parexel Biotech Brochure

    Read More
  • COVID19 The Great Decentralized Clinical Trials Accelerator

    COVID19 The Great Decentralized Clinical Trials Accelerator

    Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.

    Read More
  • Rare disease clinical trial patient identification and recruitment

    Rare disease clinical trial patient identification and recruitment

    Read More
  • Genomics & biomarkers: Answers in the blood2:56

    Genomics & biomarkers: Answers in the blood

    Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

    Watch Video
  • Getting real-world data into clinical research

    Getting real-world data into clinical research

    Learn more about how to address operational challenges that come with harnessing RWD.

    Read More
  • Top 10 Myths About Working with the FDA for an Oncology Drug Approval

    Top 10 Myths About Working with the FDA for an Oncology Drug Approval

    Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.

    Learn More
  • Endpoints That Matter2:41

    Endpoints That Matter

    Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing

    Watch Video
  • The future is now: Decentralized clinical trials during the pandemic and beyond

    The future is now: Decentralized clinical trials during the pandemic and beyond

    Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.

    Learn More
  • On-demand webinar: Value of real-world evidence and synthetic control arms

    On-demand webinar: Value of real-world evidence and synthetic control arms

    Learn about the benefits that real-world evidence (RWE) can bring to small & mid-size biotech companies.

    Watch Webinar
  • Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

    Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

    For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.

    Read More
  • COVID-19 and the impact on pediatric clinical trials

    COVID-19 and the impact on pediatric clinical trials

    The COVID-19 global pandemic has had a significant impact on the conduct of pediatric and adult clinical drug trials. Many trials have halted enrollment, and there are multiple challenges with...

    Learn More
  • COVID-19 and the effect on cellular therapy trials

    COVID-19 and the effect on cellular therapy trials

    In clinical trials for cellular and gene therapies, the COVID-19 pandemic has created enormous complexities. Parexel experts Matthew M. Cooney, MD and Roberta L. Steere offer a brief overview.

    Learn More
  • Expediting Biotech Product Development During the COVID-19 Pandemic using Modular Validation Approaches

    Expediting Biotech Product Development During the COVID-19 Pandemic using Modular Validation Approaches

    For over three months the world has been battling COVID-19. COVID-19 is unforgiving and has the ability to overwhelm even the strongest health system or regulatory regime. Even though the...

    Learn More
  • Industry Perspectives on Decentralized Clinical Trials

    Industry Perspectives on Decentralized Clinical Trials

    Read More
  • Successful wearable device selection within the clinical trials industry

    Successful wearable device selection within the clinical trials industry

    Learn more about key considerations when selecting the right wearable device for your clinical trial.

    Read More
  • The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine

    The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine

    Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more...

    Learn More
  • Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

    Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

    Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss how biotech companies can incorporate precision medicine into their development plans.

    Learn More
  • Drug development innovations that work: Precision medicine

    Drug development innovations that work: Precision medicine

    Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for regulatory bodies.

    Learn More
  • loading
    Loading More...